After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

The vaccine will only be available to those at high risk from COVID—excluding those who may need it to protect a relative or ...

Novavax (NVAX) shares climbed more than 17% premarket on Monday after the long-delayed approval of its COVID-19 vaccine from ...

By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S.

Nuvaxovid had been available under emergency use authorization but the full approval may allow it to better compete with ...

The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...

The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with unusual ...

The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.

The Food and Drug Administration will soon “unleash a massive framework” for how vaccines are tested and approved.

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...